NCT00052611 2018-03-29Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaDana-Farber Cancer InstitutePhase 2 Completed23 enrolled
NCT00058006 2012-06-11Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerNorthwestern UniversityPhase 2 Completed